| Financial Year |
March 31 2023 |
| Monetary Funds |
3,455,307,279.55 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
54,913,322.71 |
| Accounts Receivable |
2,440,287,659.57 |
| Advances to Suppliers |
91,594,446.22 |
| Other Receivables |
37,381,070.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,463,635,518.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
79,507,299.58 |
| Total Current Assets |
7,903,764,059.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
753,783,984.56 |
| Investment Properties |
13,831,237.39 |
| Fixed Assetes |
1,103,513,183.55 |
| Under-construction Projects |
341,084,405.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
332,127,671.68 |
| R&D expenses |
11,002,263.86 |
| Goodwill |
84,692,599.11 |
| Long-Term Deferred and Prepaid Expenses |
6,000,834.30 |
| Deferred Income Tax Assets |
234,389,469.87 |
| Other Non-Current Assets |
38,293,253.95 |
| Sub-Total of Non-Current Assets |
2,962,763,800.04 |
| Total Assets |
10,866,527,859.66 |
| Short-Term Loans |
351,276,795.73 |
| Trading Financial liabilities |
-- |
| Notes Payable |
594,566,945.59 |
| Accounts Payable |
686,731,735.62 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
236,086,811.32 |
| Taxes Payable |
214,681,126.36 |
| Interest Payable |
1,544,694.87 |
| Dividend Payable |
17,596,182.54 |
| Other payables |
1,348,002,914.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,305,629.23 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
3,560,725,598.61 |
| Long-term Loans |
253,540,280.39 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
40,637,621.06 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,818,245.91 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
373,095,220.71 |
| Total Liabilities |
3,933,820,819.32 |
| Paid-In Capital(Or Share Stock) |
773,443,076.00 |
| Capital Surplus |
1,027,313,427.28 |
| Surplus Reserve |
436,749,000.00 |
| LESS:Treasury Stock |
29,747,600.00 |
| Undistributed Profits |
4,667,827,968.17 |
| Minority Stockholder's Interest |
27,486,908.94 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,905,220,131.40 |
| Owner's Equity（Stockholder's Equity） |
6,932,707,040.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,866,527,859.66 |
